Contact this trialFirst, we need to learn more about you.
Behavioral Intervention
mHealth Texting Tool for Type 2 Diabetes
Recruiting1 award2 criteria
New York, New York
This trial will test a new mobile platform, MJS DIABETES, which uses text-messaging to capture patients' self-reported PROs in real-time. The platform will be integrated into the EHR system, the primary care practice and the lives of patients with T2D. A randomized control trial will be used to identify the efficacy of MJS DIABETES versus Usual Care (UC) on reduction HbA1c at 12-months, among 282 patients with T2D who receive care in safety-net practices.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service